Brian C Callaghan, MD, MS

Brian C. Callaghan, MD, MS
Professor
Professor of Neurology, Medical School
Office:
University of Michigan
Neurology
109 Zina Pitcher Pl, 4021 BSRB
Ann Arbor, Michgan 48109-2200
Email:
[email protected]
Phone:
Available to mentor
Brian C Callaghan, MD, MS
Brian C. Callaghan, MD, MS
Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    Dr. Callaghan is a Professor of Neurology and a neuromuscular specialist at the University of Michigan. He completed his medical degree and neurology residency at the University of Pennsylvania and completed a fellowship in neuromuscular disease at the University of Michigan. He also completed a master’s degree program in clinical research at the University of Michigan School of Public Health.

    Qualifications

    • Fellowship
      Center for Healthcare Research and Transformation Policy, University of Michigan, Ann Arbor, Michigan, United States
      2016 - 2016
      Postdoctoral Fellowship
    • Fellowship
      University of Michigan Health System, Neuromuscular, Ann Arbor, Michigan, United States
      2008 - 2009
      Postdoctoral Fellowship
    • Residency
      University of Pennsylvania Medical Center, Neurology, Philadelphia, Pennsylvania, United States
      2005 - 2008
      Residency
    • Internship, Preliminary Medicine
      University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
      2004 - 2005
      Internship
    • MS
      University of Michigan, Ann Arbor, Michigan, United States
      2009 - 2011
    • MD
      University of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, Pennsylvania, 19104, United States
      2000 - 2004
    • BS
      University of Michigan, Ann Arbor, Michigan, United States
      1996 - 1999

    Center Memberships

    • Center Member
      Opioid Research Institute
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Institute for Healthcare Policy and Innovation

    Research Overview

    Dr. Callaghan is interested in the treatment of painful diabetic neuropathy and other chronic pain conditions including the role of opioids. He has led the recent American Academy of Neurology guideline on the treatment of painful diabetic neuropathy and is interested in better understanding the best interventions for this common condition. Furthermore, Dr. Callaghan is interested in a better understanding of the appropriate role of opioids in chronic non cancer pain conditions.

    Recent Publications

    See All Publications
    • Journal Article
      The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity
      Reynolds EL, Watanabe M, Banerjee M, Chant E, Villegas-Umana E, Elafros MA, Gardner TW, Pop-Busui R, Pennathur S, Feldman EL, Callaghan BC. Diabetologia, 2023 Jul 1; 66 (7): 1192 - 1207. DOI:10.1007/s00125-023-05899-3
      PMID: 36917280
    • Journal Article
      Predictors of Antiamyloid Medication Utilization and Adherence Among People With Alzheimer Disease and Mild Cognitive Impairment
      Reynolds EL, Elafros MA, Muthukumar L, Shippey E, Budhu JA, Terman SW, Burke JF, Callaghan BC. Neurology, 2026 Nov 10; 107 (9): 1 - 15. DOI:10.1212/WNL.0000000000218594
      PMID: 42879726
    • Journal Article
      Longitudinal Metabolic Risk Factors Are Associated With Microvascular Complications
      Makinson CH, Park J, Feldman EL, Callaghan BC, Reynolds EL. Diabetes, Obesity and Metabolism, 2026 Sep 16; DOI:10.1111/dom.71338
    • Journal Article
      The effect of social determinants of health on use of diabetes-related mobile health applications in older adults with type 2 diabetes
      Damilola A, Makinson C, Elafros MA, Mizokami-Stout K, Feldman EL, Callaghan BC, Reynolds EL. Diabetic Medicine, 2026 Sep 16; DOI:10.111/dme.70464
    • Journal Article
      Comparing the Diagnostic Characteristics of Neuropathy Questionnaires in Adults With Obesity
      Heaton N, Reynolds EL, Koenig F, Muthukumar L, Huijg M, Taams NE, van Doorn PA, Callaghan BC. Journal of the Peripheral Nervous System, 2026 Sep 1; 31 (3): DOI:10.1111/jns.70163
      PMID: 42629177
    • Journal Article
      Impact of modifiable risk factors, including diabetes, and diabetes-related complications, on dementia risk in older U.S. adults: mutually adjusted estimates from a population-based cohort
      Wiggers A, Muthukumar L, Reynolds EL, Nilsson M, Hansen CS, Rungby J, Feldman EL, Callaghan BC. Diabetes Research and Clinical Practice, 2026 Sep 1; 239: DOI:10.1016/j.diabres.2026.113457
      PMID: 42486408
    • Journal Article
      Metabolic and Microvascular Risk Factors Associated With Brain Health in Type 1 Diabetes
      Park J, Koubek EJ, Beare R, Ang L, Callaghan BC, Pop-Busui R, Feldman EL, Reynolds EL. Annals of Clinical and Translational Neurology, 2026 Sep 1; 13 (9): 1937 - 1946. DOI:10.1002/acn3.70428
      PMID: 42117336
    • Journal Article
      The Erasmus—Polyneuropathy Symptom Score for the Screening of Chronic Axonal Polyneuropathy: A Validation Study
      Taams NE, Huijg M, Vermeij FH, Kuitwaard K, Hanewinckel R, de Beukelaar J, Reynolds EL, Callaghan BC, Ikram MA, van Doorn PA. Journal of the Peripheral Nervous System, 2026 Sep 1; 31 (3): DOI:10.1111/jns.70143
      PMID: 42442712

    Featured News & Stories

    prescription pad drawn
    Health Lab

    Who gets Alzheimer’s drugs? Race, vulnerability and health status shape access

    A Michigan Medicine study found major disparities in access to new Alzheimer’s drugs, with Black and Hispanic patients less likely to receive treatment, though adherence was similar once therapy began.
    Department News

    Who gets Alzheimer's drugs? Race, vulnerability and health status shape access

    The findings, published in Neurology, highlight potential disparities in access to a new class of Alzheimer's treatments as use of these therapies increases.
    the screen of a mobile phone with a diabetes app opened
    Research News

    Who uses mobile apps for diabetes?

    Diabetic Medicine published research on the use of mobile apps for diabetes in older adults and whether social determinants of health affect their use.
    Department News

    'We Cannot Distinguish Fake From Real': What We Heard This Week

    Brian Callaghan, MD, MS, of the University of Michigan in Ann Arbor, commenting on a study showing gabapentin prescribing surged after Michigan descheduled the drug.
    Department News

    Gray Areas: Realistic Possibility of Reversing Diabetic Neuropathy

    Brian Callaghan, MD, MS, professor of neurology at the University of Michigan, discusses the clinical debate around whether diabetic peripheral neuropathy is reversible if diagnosed and treated early enough.
    a brain covered in sugar
    Research News

    Dementia and diabetes

    Our study, published in Diabetes Research and Clinical Practice, examined whether diabetes and related complications increase dementia risk independent of other risk factors.